PAHC
PHIBRO ANIMAL HEALTH CORP
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$38.49
−2.40%Price chart
Oct 7Oct 12Oct 15Oct 20Oct 23Oct 28Nov 2Nov 5
Key dataNov 5, 2026
Open$38.54
From 52W high−35.41%
Volume43000.00
Market cap$1.56B
P/E (TTM)15.6x
P/S (TTM)1.0x
Div yield1.25%
Key dataNov 5, 2026
Open
$38.54
From 52W high
−35.41%
Volume
43000.00
Market cap
$1.56B
ValuationView details →
P/E (Fwd)
10.9x
EV/EBITDA
9.6x
P/E (TTM)
15.6x
RSI (14)
56.4
MomentumView details →
1D Return
−2.40%
YTD Return
+4.47%
SummaryUpdated Sep 1, 2026
Phibro Animal Health Corporation (NASDAQ:PAHC) is a specialty animal health company that develops, manufactures, and markets products for livestock and companion animals. Founded as Philipp Brothers Chemicals in the early 20th century, the company changed its name to Phibro Animal Health Corporation in 2003 and went public in 2014. Headquartered in Teaneck, New Jersey, Phibro operates globally with manufacturing facilities in the United States, Brazil, and Ireland, serving customers across North America, Latin America, Europe, Asia Pacific, and other international markets.
Similar companies
Latest newsMore news →
PHIBRO ANIMAL HEALTH CORP maintained its financial guidance for the year ending June 30, 2027.18h agoPHIBRO ANIMAL HEALTH CORP reported first-quarter net sales of $386.8 million and net income of $29.5 million for the quarter ended September 30, 2026.18h agoPHIBRO ANIMAL HEALTH CORP declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock.2d ago